Julian is an associate in the firm’s litigation department, where his practice focuses principally on general commercial litigation matters. He advises plaintiffs and defendants on a wide range of business torts and contractual disputes and has litigated cases in numerous state and federal courts. Julian’s practice also includes government enforcement matters, in which he represents businesses in connection with investigations by state and federal regulators. In his varied and active pro bono practice, Julian has advised low-income artists with respect to copyright, trademark, and First Amendment issues, and has represented political asylum seekers.
Before joining the firm, Julian served as an Attorney Fellow at Public Citizen Litigation Group in Washington, DC, where he handled consumer class actions and matters involving FOIA, grand jury secrecy, the Federal Arbitration Act, and the Federal Food Drug and Cosmetic Act.
General Commercial Litigation
- Representing privately owned investment fund as the plaintiff in a derivative suit in New York for breach of fiduciary duty.
- Representing independent broker-dealer as the defendant in a breach-of-contract suit in Delaware Chancery court, and an affiliated entity as the defendant in a suit in New Jersey superior court alleging tortious interference with prospective advantage.
- Representing real estate development firm in contract disputes in federal courts in Ohio and New York
- Represented system of hospitals and other health care facilities as the defendant in a breach-of-contract suit in New York state court.
- Represented directors of private equity firm portfolio company in connection with proceedings in bankruptcy court in the Southern District of Florida.
- Represented international financial services firm in state and federal investigations into residential mortgage-backed securities.
Constitutional and Appellate Matters
- Represented pharmaceutical manufacturer and physicians in litigation against FDA in federal court in New York, challenging on First Amendment and other grounds regulations governing pharmaceutical manufacturers’ truthful, non-misleading speech about their products.
- Represented a variety of advocacy organizations as amicus curiae on the merits in Millbrook v. United States, a case in the U.S. Supreme Court regarding the Federal Tort Claims Act.
- Douglas Hallward-Driemeier, Adam Stein and Julian Helisek, “Against Convergence: Mounting a Legal Challenge to FASB’s Adoption of International Accounting Standards,” Bloomberg Law Reports (February 2012)
- "The Fault, Dear PCAOB, Lies Not in the Appointments Clause, but in the Removal Power, That You Are Unconstitutional," 77 Geo. Wash. L. Rev. 1063 (2009)